| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Australia | 2 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | United States | 2 | |
| #6 | Brazil | 1 | |
| #7 | Canada | 1 | |
| #8 | Israel | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds | |
| #5 | Diagnosis and surgery |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kagimoto Tadahisa | 15 |
| #2 | Ishibashi Tatsuro | 13 |
| #3 | Fujisawa Kimihiko | 12 |
| #4 | Hata Yasuaki | 8 |
| #5 | Sasa Yukio | 5 |
| #6 | Azuma Kaoru | 2 |
| #7 | Tatsuro Ishibashi | 2 |
| #8 | Yoneda Shigeyuki | 2 |
| #9 | Wada Atsushi | 2 |
| #10 | Kimihiko Fujisawa | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2008044339A1 | Therapeutic/preventive agent for intraocular disease containing statin compound | |
| WO2008026320A1 | ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT | |
| WO2007135781A1 | Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy | |
| WO2008117338A1 | Oxygen consumption measurement system and diagnostic system | |
| US2009270315A1 | Method of inhibiting angiogenesis by using ephrin b2 | |
| CA2561841A1 | Methods for suppressing neovascularization using ephrinb2 |